Affiliation: Heinrich Heine University
- Epidemiology and clinical characteristics of pandemic (H1N1) 2009 influenza infection in pediatric hemato-oncology and hematopoietic stem cell transplantation patientsF Babor
Department of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Heinrich Heine University, Medical Faculty, Dusseldorf, Germany
Transpl Infect Dis 14:589-94. 2012..For children with hemato-oncologic diseases, especially after hematopoietic stem cell transplantation (HSCT), the risk for developing complications related to pandemic influenza A (H1N1) 2009 (pH1N1) infection is largely unknown...
- Successful management of neonatal hemochromatosis by exchange transfusion and immunoglobulin: a case reportF Babor
Department for Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Heinrich Heine University, Dusseldorf, Germany
J Perinatol 33:83-5. 2013..The subsequent favorable course of the disease is described in this case report...
- Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurementF Babor
Department of Pediatric Oncology, Hematology and Immunology, Center for Child and Adolescent Health, Heinrich Heine University, Moorenstrasse 5, Duesseldorf, Germany
Klin Padiatr 224:160-5. 2012..Survival after 2 years was 50% for patients with AML and IA. In patients with high risk to develop IA the effect of intensified, intravenous antimycotic prophylaxis has to be proven prospectively in a cooperative and randomized setting...